Neuigkeiten

Neuigkeiten aus dem GMP-Umfeld und von der Valicare GmbH

Nachrichten aus aller Welt

Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).

Interleukin-17A promotes the differentiation of bone marrow mesenchymal stem cells into neuronal cells

17.01.2021 | Science Direct

Highlights • 20 ng/mL is the optimum concentration of IL-17A to promote neuronal differentiation of BMSCs. • IL-17 promotes cell ...

University of Florida Health researchers win $75 million grant to help develop new antibiotic

16.01.2021 | Alachua Chronicle

Courtesy of UF Health BY DOUG BENNETT In the medical and military fields, antibiotic-resistant bacteria can be formidable foes. Now, ...

Sartorius : Partners With RoosterBio to Advance Cell and Gene Therapy Manufacturing | MarketScreener

15.01.2021 | Market Screener

Sartorius Partners With RoosterBio to Advance Cell and Gene Therapy Manufacturing Göttingen, January 15, ...

Automatisierte Verfahren mittels reprogrammierter Blutzellen entwickelt

15.01.2021 | LABO.de

Large decline in cancer mortality

14.01.2021 | Healthcare Economist

Last year, I published a paper that showed that cancer mortality rates fell by 24% between 2000 and 2016 and further that new cancer drugs ...

Biomaterials direct functional B cell response in a material specific manner

14.01.2021 | bioRxiv

B cells are an adaptive immune target of biomaterials development in vaccine research but despite their role in wound healing have not been ...

Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections

13.01.2021 | DocWire News

This article was originally published here Biomedicines. 2021 Jan 9;9(1):E59. doi: 10.3390/biomedicines9010059. ABSTRACT Adoptive cell ...

Cardiotoxic mechanisms of cancer immunotherapy – A systematic review

13.01.2021 | Science Direct

Highlights • Active immunotherapies include anti-tumour vaccines and CAR T-cells. • Passive agents are antibodies, checkpoint inhibitors, ...

Curocell readies clinical trial of revolutionary CAR-T cell therapy

13.01.2021 | Pulse by Maeil Business News

Curocell, a South Korean biotech startup that has pioneered chimeric antigen receptor T (CAR-T) cell therapy, is prepping to kick off a ...

Neuartiger Therapieansatz gegen COVID-19

12.01.2021 | Frankfurt-Live

Process Development: 2020 Reflections and 2021 Possibilities

11.01.2021 | http://www.processdevelopmentforum.com

The challenges posed by the COVID-19 pandemic in 2020 brought about many unprecedented lessons and promising developments in the ...

The 21 European Biotech Companies to Watch in 2021

11.01.2021 | Labiotech.eu

Platform-Disease Fit: Why You Need It and How to Find It

08.01.2021 | Andreessen Horowitz

It’s Time to Heal is a special package about engineering the future of bio and healthcare. See more at: https://a16z.com/time-to-heal/. In ...

Mini-Organe aus dem 3D-Drucker Zwei neue Forschungszentren setzen auf Hightech

08.01.2021 | Berliner Woche

GeneOne to supply plasmid DNA therapy worth $2 million to US

08.01.2021 | Korea Biomedical Review

GeneOne Life Science Inc. said Friday it has signed a contract to supply plasmid DNA therapy worth $2 million to a U.S. biopharmaceutical ...

Wir sind für Sie da

Kontaktieren Sie uns, wenn Sie Fragen haben. Wir antworten und beraten Sie gerne. 

Kontakt